Pay in 4 interest-free payments of $6.08 Learn more
Ships within 48 hours · Estimated delivery Aug 31 - Sep 5
Increasing diagnosis rates among adolescents and young adults are fueling treatment demand across the region
It is important to distinguish between causation and correlation when patients report new symptoms during treatment
Cahill, Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee, and colleagues, therefore, aimed to compare rates of asthma exacerbations and symptoms between adults with type 2 diabetes and asthma prescribed GLP-1R agonists and those prescribed SGLT-2 (sodiumglucose cotransporter-2) inhibitors, DPP-4 (dipeptidyl peptidase-4) inhibitors, sulfonylureas, or basal insulin for diabetes treatment intensification
Studies link the use of these medications to a significant increase in the risk of gallbladder disease
Tincopa-Wong OW
10.1152/ajpheart.00209.2014
US$ 27.40
US$ 28.42
US$ 29.00
US$ 20.38
US$ 29.67
US$ 21.43
US$ 23.03
US$ 26.62
